ArticleMaterials today. Bio2023

Combination of IDO inhibitors and platinum(IV) prodrugs reverses low immune responses to enhance cancer chemotherapy and immunotherapy for osteosarcoma.

Dongquan Xiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.